Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases (Q35229068)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases |
scientific article |
Statements
1 reference
Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases (English)
1 reference
Srihari Gopal
1 reference
Larry Alphs
1 reference
Keith Karcher
1 reference
Justine Kent
1 reference
Jennifer Kern Sliwa
1 reference
Stuart Kushner
1 reference
Isaac Nuamah
1 reference
Jaskaran Singh
1 reference
1 February 2011
1 reference
1 reference
6
1 reference
1
1 reference
43-45
1 reference
Identifiers
1 reference
1 reference
1 reference